U.S. FDA grants termination of Stat Medical Devices’ recall of insulin pen needles.
October 20, 2010 – STAT Medical Devices, Inc.® Miami-based STAT Medical Devices, Inc.® has been granted a formal termination of the voluntary recall of their insulin pen needles from the Food & Drug Administration, Department of Health and Human Services.
STAT Medical Devices hires new Director of Sales.
April 2, 2009 – STAT Medical Devices, Inc.® has appointed Tom Gannon, BS, RN, CDE, to oversee domestic and international sales for STAT’s brand of products as well as STAT’s Private Label Division and OEM/ODM Design and Manufacturing Services.